Processa Pharmaceuticals (PCSA) said Tuesday it has priced a public offering to raise $7 million, with H.C. Wainwright as its placement agent.
The company said it is offering 28 million shares and warrants to purchase up to the same number of shares at $0.25 per share and warrant. Investors can also buy pre-funded warrants in lieu.
Processa said it expects to close the offering June 18, with funds raised to be used for its phase 2 trial of NCG-Cap, and for working capital and general corporate purposes.
The shares were up over 27% in recent trading.
Price: 0.29, Change: +0.06, Percent Change: +27.32
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.